Page last updated: 2024-08-23

ursodeoxycholic acid and Muscular Dystrophy, Duchenne

ursodeoxycholic acid has been researched along with Muscular Dystrophy, Duchenne in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bertoldo, M; Bovolenta, M; Capobianco, ML; Mamchaoui, K; Marchesi, E; Perrone, D; Preti, L1
Berge, J; Bledsoe, C; Carlson, CG; Gatti, F; Lavin, J; Millman, G; Palmeiri, B; Rutter, J; Siegel, AL; Turin, E; Winders, WT1

Other Studies

2 other study(ies) available for ursodeoxycholic acid and Muscular Dystrophy, Duchenne

ArticleYear
Synthesis and Exon-Skipping Properties of a 3'-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting
    Molecules (Basel, Switzerland), 2021, Dec-17, Volume: 26, Issue:24

    Topics: Cell Line, Transformed; Exons; Humans; Muscular Dystrophy, Duchenne; Myoblasts, Skeletal; Oligonucleotides, Antisense; RNA Precursors; Ursodeoxycholic Acid

2021
Treatment with inhibitors of the NF-kappaB pathway improves whole body tension development in the mdx mouse.
    Neuromuscular disorders : NMD, 2009, Volume: 19, Issue:2

    Topics: Animals; Antioxidants; Cholagogues and Choleretics; Disease Models, Animal; Female; Male; Mice; Mice, Inbred mdx; Muscle Strength; Muscle Stretching Exercises; Muscle Tonus; Muscle Weakness; Muscle, Skeletal; Muscular Dystrophy, Duchenne; NF-kappa B; Pyrrolidines; Recovery of Function; Thiocarbamates; Transcription Factor RelA; Treatment Outcome; Ursodeoxycholic Acid

2009